Mai Capital Management Organon & Co. Transaction History

Mai Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$17.45 - $21.96 $280,945 - $353,556	16,100 Added 154.38%	26,529 $549,000
Q1 2024 May 08, 2024	BUY	$13.78 - $18.8 $143,711 - $196,065	10,429 New	10,429 $196,000
Q2 2022 Jul 19, 2022	SELL	$31.66 - $38.9 $187,458 - $230,326	-5,921 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$30.45 - $39.36 $180,294 - $233,050	5,921 New	5,921 $207,000
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $201,607 - $261,098	-7,032 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $15,775 - $19,637	-551 Reduced 7.27%	7,032 $231,000
Q2 2021 Jul 19, 2021	BUY	$28.45 - $38.0 $215,736 - $288,154	7,583 New	7,583 $229,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.